Andreas Lill

Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors

Sebastian Barzen, Carmen B. Rödl, Andreas Lill et al. · Bioorganic & Medicinal Chemistry · 2012 · 20 citations · Full text

Medicinal Chemistry, Potent 5-Lipoxygenase Inhibitors, Biochemistry +7

Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy

Andreas Lill, Carmen B. Rödl, Dieter Steinhilber et al. · European Journal of Medicinal Chemistry · 2014 · 17 citations · Full text

Medicinal Chemistry, Heterocyclic, Pharmacology +7

Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties

Daniel Flesch, Matthias Gabler, Andreas Lill et al. · Bioorganic & Medicinal Chemistry · 2015 · 17 citations · Full text

Molecular Pharmacology, Biochemistry, G Protein-coupled Receptor +8

Synthesis of novel dansyl-labeled Celecoxib derivatives

Andreas Lill, Klaus Scholich, Holger Stark · Tetrahedron Letters · 2013 · 11 citations

Medicinal Chemistry, Derivative (Chemistry), Medicine +5